On March 28, 2024, Digital Therapeutics, Inc. closed the transaction. The company issued 3,304,730 Series C Preferred Stock at an issue price of $17.5506 per share for gross proceeds of $57,999,994? led by a returning investors, Atomico Investment Holdings Limited with participation from returning investors, Octopus Ventures Ltd., Y Combinator Management, LLC, Kinnevik AB and new investors, GreyMatter BrainTrust LLC, Eight Roads Ventures.

The company has raised a total of $151 million in funding till date. As part of this round, Laura Connell from Atomico Investment Holdings Limited will join the company's board. The company has received $50,499,903 from 10 investors pursuant to Regulation D.